• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病(COVID-19):临床观点与持续挑战

Coronavirus Disease 2019 (COVID-19): Clinical Perspectives and Ongoing Challenges.

作者信息

Arawomo A O, Ajibade A I, Adeniyi B, Aigbirior J, Erhabor G E

机构信息

Department of Medicine,Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife,Nigeria.

Department of Medicine,Federal Medical Centre, Owo,Nigeria.

出版信息

West Afr J Med. 2020 Jul-Aug;37(3):295-316.

PMID:32476126
Abstract

BACKGROUND

Emerging infectious diseases pose a great hazard to public health and the global economy. A novel coronavirus, SARS-CoV-2, causing coronavirus disease 2019 (COVID-19), emerged from Wuhan, China, in December 2019. Since then, it has spread globally causing a global health emergency of inconceivable magnitude, with significant morbidity and mortality. There is the need for clinicians and health care providers to understand and gain knowledge of the different aspects of the disease as it evolves.

OBJECTIVE

We reviewed existing literature on COVID-19 in order to present a synopsis of current understanding of the disease.

METHODS

Using PubMed, Embase and Medline, articles published between January and April 2020 on Coronavirus disease 2019 (COVID-19), and resources from World Health Organisation were analyzed in order to have an understanding of the clinical characteristics, transmission dynamics, virology, diagnostic possibilities, prevention, management approach, controversies and impact of COVID-19 on the healthcare workforce.

RESULTS

Our review revealed that COVID-19 patients present with a myriad of symptoms, ranging from mild to severe respiratory disease, which can often be fatal. The mode of transmission via droplet infections makes it unduly contagious and difficult to control. Currently, antiviral drugs or vaccines are being developed to manage this condition.

CONCLUSION

There is urgent need for potent antivirals and vaccine to manage those infected with COVID 19 and prevent infection. Global efforts need to be unified in combating this public health emergency and flattening the curve of spread.

摘要

背景

新发传染病对公众健康和全球经济构成巨大危害。2019年12月,一种新型冠状病毒,即严重急性呼吸综合征冠状病毒2型(SARS-CoV-2),在中国武汉出现,引发了2019冠状病毒病(COVID-19)。自那时以来,它已在全球传播,造成了一场规模难以想象的全球卫生紧急事件,导致了大量发病和死亡。随着疾病的演变,临床医生和医疗保健提供者需要了解并掌握该疾病不同方面的知识。

目的

我们回顾了关于COVID-19的现有文献,以便概述目前对该疾病的认识。

方法

利用PubMed、Embase和Medline数据库,分析了2020年1月至4月期间发表的关于2019冠状病毒病(COVID-19)的文章,以及世界卫生组织的相关资源,以了解COVID-19的临床特征、传播动态、病毒学、诊断方法、预防措施、管理方法、争议以及对医护人员的影响。

结果

我们的综述显示,COVID-19患者表现出各种各样的症状,从轻度到重度呼吸道疾病,后者往往可能致命。通过飞沫感染的传播方式使其具有极强的传染性且难以控制。目前,正在研发抗病毒药物或疫苗来应对这种情况。

结论

迫切需要有效的抗病毒药物和疫苗来治疗COVID-19感染者并预防感染。全球需要统一努力来应对这一公共卫生紧急事件并减缓传播曲线。

相似文献

1
Coronavirus Disease 2019 (COVID-19): Clinical Perspectives and Ongoing Challenges.2019冠状病毒病(COVID-19):临床观点与持续挑战
West Afr J Med. 2020 Jul-Aug;37(3):295-316.
2
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
3
The Coronavirus Pandemic: What Does the Evidence Show?新冠疫情:证据表明了什么?
J Nepal Health Res Counc. 2020 Apr 19;18(1):1-9. doi: 10.33314/jnhrc.v18i1.2596.
4
Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population.新型冠状病毒(COVID-19)大流行的临床洞察系统评价:美国农村人口的持续挑战。
Int J Environ Res Public Health. 2020 Jun 15;17(12):4279. doi: 10.3390/ijerph17124279.
5
Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China.2019冠状病毒病:一种源自中国武汉的新型严重急性呼吸综合征。
Acta Virol. 2020;64(2):245-250. doi: 10.4149/av_2020_201.
6
[Epidemiology and control of COVID-19].[新型冠状病毒肺炎的流行病学与防控]
Dtsch Med Wochenschr. 2020 May;145(10):670-674. doi: 10.1055/a-1162-1987. Epub 2020 Apr 28.
7
A new era for nuclear medicine.核医学的新时代。
Hell J Nucl Med. 2020 Jan-Apr;23(1):2-3. doi: 10.1967/s002449912013.
8
Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.全球冠状病毒病 COVID-19/严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫情及相关事件的地理追踪和制图:21 世纪 GIS 技术如何支持全球抗击疫情和传染病。
Int J Health Geogr. 2020 Mar 11;19(1):8. doi: 10.1186/s12942-020-00202-8.
9
As We Went to Press: COVID-19 Continues to Spread.见报时:COVID-19 持续传播。
Am J Nurs. 2020 Apr;120(4):15. doi: 10.1097/01.NAJ.0000659956.26994.75.
10
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.SARS-CoV-2 RNA 存在于 COVID-19 患者的粪便中。
J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.

引用本文的文献

1
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.南非腹部手术患者中术前洗必泰含漱液预防术后肺炎的成本效果初步模型评估。
PLoS One. 2021 Aug 12;16(8):e0254698. doi: 10.1371/journal.pone.0254698. eCollection 2021.